The potential of nasal sprays for vaccination

Do vaccines delivered via a soft mist nasal spray device hold the key to an enhanced immunization response?

While the COVID-19 pandemic was marked by the number of successes achieved by the pharmaceutical industry, it’s clear that there are still lessons to be learnt about improving our response to the next viral threat. One vitally important hurdle to overcome, though, is the need to improve the way we deliver vaccines; solutions to provide better efficacy and even more convenience during administration are essential.

The potential of nasal administration

Recent studies suggest that vaccine delivery via the mucosal membrane provides a better, longer-lasting effect than traditional injections, even at a lower dose. Developing nasal vaccines might also offer benefits compared with injectables owing to their non-invasive, more targeted means of delivery. As a result, nasal vaccines could offer reduced side-effects, a faster response and a better patient experience. Moreover, the nasal delivery of a vaccine would negate any hesitancy caused by needles among patients, like needle phobia.

Want to know more about the challenges that need to be addressed and how the new generation of soft mist nasal sprays offers the ability to navigate these challenges? Click here!